Education
About Us
Working with TipRanks
Follow Us
Staar Surgical (STAA)
NASDAQ:STAA
STAA Stock Chart & Stats
Day’s Range― - ―
52-Week Range$13.50 - $52.68
Previous CloseN/A
Volume326.32K
Average Volume (3M)1.19M
Market Cap
$869.61M
Enterprise Value$1.00B
Total Cash (Recent Filing)$8.49M
Total Debt (Recent Filing)$4.20M
Price to Earnings (P/E)55.8
Beta0.58
Next Earnings
Apr 30, 2025EPS Estimate
-0.58Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.41
Shares Outstanding49,325,370
10 Day Avg. Volume990,319
30 Day Avg. Volume1,189,082
Financial Highlights & Ratios
PEG Ratio5.37
Price to Book (P/B)N/A
Price to Sales (P/S)2.78
Price to Cash Flow (P/CF)340.40
P/FCF Ratio0.00
Enterprise Value/Market Cap1.15
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit4.18
Enterprise Value/Ebitda-175.00
Forecast
1Y Price Target
$16.83Price Target Upside-4.38% Downside
Rating ConsensusHold
Number of Analyst Covering9
---
Staar Surgical News
PremiumCompany Announcements
Staar Surgical Announces Leadership Realignment for Growth
PremiumCompany Announcements
Staar Surgical Announces New Leadership Transition
PremiumCompany Announcements
STAAR Surgical Faces China Challenges Amid Global Growth---
Bulls Say, Bears Say
Bulls Say
Business GrowthPerformance in STAA’s business ex-China continues to do well, with Q4 ex-China revenue ahead of expectations and growth observed in the US business.
Financial StabilityThe company has $230M in cash and equivalents with no debt, which will allow it to weather macroeconomic headwinds.
LeadershipThe appointment of Stephen Farrell as CEO, who brings over 20 years of C-suite experience in healthcare and biotech industries, is expected to positively impact STAAR Surgical's strategic direction.
Bears Say
China MarketChina headwinds are worsening, impacting more than 50% of the company's sales.
Inventory LevelsThe company disclosed elevated distributor inventory levels in China and expects minimal sales, further constraining visibility.
Market ChallengesMacroeconomic headwinds will continue to challenge demand for EVO, despite the high quality of the product.
---
Ownership Overview
44.52% Insiders
19.04% Mutual Funds
0.11% Other Institutional Investors
7.27% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Legal & RegulatoryLitigation, compliance, new legislation, and taxation risks
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
STAA FAQ
What was Staar Surgical’s price range in the past 12 months?
Staar Surgical lowest stock price was $13.50 and its highest was $52.68 in the past 12 months.
What is Staar Surgical’s market cap?
Staar Surgical’s market cap is $869.61M.
When is Staar Surgical’s upcoming earnings report date?
Staar Surgical’s upcoming earnings report date is Apr 30, 2025 which is in 26 days.
How were Staar Surgical’s earnings last quarter?
Staar Surgical released its earnings results on Feb 11, 2025. The company reported -$0.514 earnings per share for the quarter, missing the consensus estimate of -$0.027 by -$0.487.
Is Staar Surgical overvalued?
According to Wall Street analysts Staar Surgical’s price is currently Overvalued.
Does Staar Surgical pay dividends?
Staar Surgical does not currently pay dividends.
What is Staar Surgical’s EPS estimate?
Staar Surgical’s EPS estimate is -0.58.
How many shares outstanding does Staar Surgical have?
Staar Surgical has 49,325,370 shares outstanding.
What happened to Staar Surgical’s price movement after its last earnings report?
Staar Surgical reported an EPS of -$0.514 in its last earnings report, missing expectations of -$0.027. Following the earnings report the stock price went down -24.68%.
Which hedge fund is a major shareholder of Staar Surgical?
Currently, no hedge funds are holding shares in STAA
---
Staar Surgical Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
$16.83 (-4.38% Downside)
$16.83 (-4.38% Downside)
Blogger Sentiment
Bullish
STAA Sentiment 66%
Sector Average 69%
Sector Average 69%
Hedge Fund Trend
Increased
By 41.5K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Bought Shares
Worth $27.6M over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Positive
Last 7 Days ▲ 2.0%
Last 30 Days ▲ 0.6%
Last 30 Days ▲ 0.6%
News Sentiment
Neutral
Bullish news 50%
Bearish news 100%
Bearish news 100%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-54.91%
12-Months-Change
Fundamentals
Return on Equity
-5.16%
Trailing 12-Months
Asset Growth
4.26%
Trailing 12-Months
Company Description
Staar Surgical
Staar Surgical (STAA) is a leading medical device company that specializes in the design, development, manufacture, and marketing of implantable lenses for the eye. The company operates primarily in the ophthalmic sector, offering products that are intended to provide visual improvement by correcting refractive errors such as myopia, hyperopia, and astigmatism. Staar Surgical is recognized for its innovative Implantable Collamer Lenses (ICLs), which serve as an alternative to traditional corrective lenses and surgical procedures, enhancing vision without the removal of corneal tissue.
---
STAA Company Deck
---
STAA Earnings Call
Q4 2025
0:00 / 0:00
Earnings Call Sentiment|Negative
STAAR Surgical faced significant challenges in China, which overshadowed strong performance in other regions. While the company continues to grow outside of China and gain market share in the U.S., the decline in China sales and the unrecognized revenue due to extended payment terms have negatively impacted overall results. The company remains optimistic about future growth and recovery, particularly in China, but the current challenges have led to a cautious outlook for fiscal 2025.Read More>---
STAA Stock 12 Month Forecast
Average Price Target
$16.83
▼(-4.38% Downside)
Technical Analysis
Baxter International
―
Boston Scientific
―
Edwards Lifesciences
―
ICU Medical
―
Zimmer Biomet Holdings
―
Best Analysts Covering STAA
1 Year
1 Year Success Rate
1/11 ratings generated profit
1 Year Average Return
-43.08%
reiterated a buy rating last month
Copying Thomas Stephan's trades and holding each position for 1 Year would result in 9.09% of your transactions generating a profit, with an average return of -43.08% per trade.
---